AR060836A1 - Un disco trans-mucosa para administrar un agente activo, una composicion trans-mucosa y el metodo de administracion obtenido - Google Patents

Un disco trans-mucosa para administrar un agente activo, una composicion trans-mucosa y el metodo de administracion obtenido

Info

Publication number
AR060836A1
AR060836A1 ARP070101896A ARP070101896A AR060836A1 AR 060836 A1 AR060836 A1 AR 060836A1 AR P070101896 A ARP070101896 A AR P070101896A AR P070101896 A ARP070101896 A AR P070101896A AR 060836 A1 AR060836 A1 AR 060836A1
Authority
AR
Argentina
Prior art keywords
trans
mucosa
composition
active agent
disk
Prior art date
Application number
ARP070101896A
Other languages
English (en)
Inventor
Amarjit Singh
Sarabjit Singh
Shivanand Puthli
Original Assignee
Panacea Biotec Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panacea Biotec Ltd filed Critical Panacea Biotec Ltd
Publication of AR060836A1 publication Critical patent/AR060836A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Inorganic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Una composicion para suministrar agentes activos a través de administracion trans-mucosa, más particularmente a través de la mucosa bucal. La composicion es un disco trans-mucosa unico que tiene dos compartimientos, que consisten en al menos un agente activo y al menos un agente muco-adhesivo y ambos compartimientos están adaptados para estar en contacto con la membrana de mucosa. La composicion provee buena estabilidad y efectividad, es versátil, fácil de fabricar, comoda para el usuario y permite el control sobre la dosis y el efecto de los agentes activos. Un método de administracion trans-mucosa de un agente activo y método de tratamiento de enfermedades en un individuo que necesita dicho tratamiento.
ARP070101896A 2006-05-02 2007-05-02 Un disco trans-mucosa para administrar un agente activo, una composicion trans-mucosa y el metodo de administracion obtenido AR060836A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN682MU2006 2006-05-02

Publications (1)

Publication Number Publication Date
AR060836A1 true AR060836A1 (es) 2008-07-16

Family

ID=38655912

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP070101896A AR060836A1 (es) 2006-05-02 2007-05-02 Un disco trans-mucosa para administrar un agente activo, una composicion trans-mucosa y el metodo de administracion obtenido

Country Status (11)

Country Link
US (1) US20090110717A1 (es)
EP (1) EP2015779A2 (es)
JP (1) JP2009535397A (es)
KR (1) KR20090029710A (es)
CN (1) CN101437546A (es)
AR (1) AR060836A1 (es)
AU (1) AU2007245265A1 (es)
BR (1) BRPI0711168A2 (es)
CA (1) CA2650040A1 (es)
RU (1) RU2008147413A (es)
WO (1) WO2007125545A2 (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2696341C (en) * 2007-08-13 2016-05-17 Abuse Deterrent Pharmaceutical Llc Abuse resistant drugs, method of use and method of making
US20090060983A1 (en) * 2007-08-30 2009-03-05 Bunick Frank J Method And Composition For Making An Orally Disintegrating Dosage Form
CA2704209C (en) * 2007-10-31 2017-02-28 Mcneil-Ppc, Inc. Orally disintegrative dosage form
WO2009141309A1 (en) * 2008-05-20 2009-11-26 N.V. Organon Delivery system for paliperidone
WO2011027322A1 (en) * 2009-09-03 2011-03-10 Ranbaxy Laboratories Limited Extended release dosage form containing olopatadine for oral administration
US8858210B2 (en) 2009-09-24 2014-10-14 Mcneil-Ppc, Inc. Manufacture of variable density dosage forms utilizing radiofrequency energy
US9610224B2 (en) 2009-09-24 2017-04-04 Johnson & Johnson Consumer Inc. Manufacture of tablet in a die utilizing powder blend containing water-containing material
US20110070286A1 (en) * 2009-09-24 2011-03-24 Andreas Hugerth Process for the manufacture of nicotine-comprising chewing gum and nicotine-comprising chewing gum manufactured according to said process
CN102048711B (zh) * 2009-11-11 2013-06-05 河北奥星集团药业有限公司 一种格拉司琼膜制剂及其制备方法
CN103347506A (zh) 2010-10-12 2013-10-09 约翰.霍普金斯大学 包含美金刚的镇咳组合物
US20130274342A1 (en) * 2012-04-12 2013-10-17 Cerecor, Inc. Compositions and methods for treating cough
US9511028B2 (en) 2012-05-01 2016-12-06 Johnson & Johnson Consumer Inc. Orally disintegrating tablet
US9233491B2 (en) 2012-05-01 2016-01-12 Johnson & Johnson Consumer Inc. Machine for production of solid dosage forms
US20130295174A1 (en) * 2012-05-01 2013-11-07 Mcneil-Ppc, Inc. Tablet comprising a first and second region
US9445971B2 (en) 2012-05-01 2016-09-20 Johnson & Johnson Consumer Inc. Method of manufacturing solid dosage form
WO2013188819A2 (en) * 2012-06-14 2013-12-19 Entrega, Inc. Mucoadhesive devices for delivery of active agents
KR20160107254A (ko) 2014-01-10 2016-09-13 존슨 앤드 존슨 컨수머 인코포레이티드 고주파 및 손실 코팅된 입자를 사용하여 정제를 제조하는 방법
CN106822007B (zh) 2015-09-11 2021-12-31 西姆莱斯股份公司 口服制剂
CN106074457A (zh) * 2016-06-30 2016-11-09 合肥华方医药科技有限公司 一种盐酸奥洛他定口腔速溶膜及其制备方法
CN106333924A (zh) * 2016-07-28 2017-01-18 顾世海 一种含喜树碱类化合物的药物制剂
CN106474095B (zh) * 2016-11-15 2021-03-26 宁波百思佳医药科技有限公司 一种用于治疗口腔真菌的口腔粘膜粘贴剂及其制备方法
US10493026B2 (en) 2017-03-20 2019-12-03 Johnson & Johnson Consumer Inc. Process for making tablet using radiofrequency and lossy coated particles
WO2019004088A1 (ja) * 2017-06-27 2019-01-03 株式会社バイオセレンタック 粘膜付着性経口製剤
RU2699808C2 (ru) * 2017-12-05 2019-09-11 Общество с ограниченной ответственностью "Эндокринные технологии" Биоразлагаемая система трансмукозальной доставки дротаверина
RU2729659C1 (ru) * 2019-05-29 2020-08-11 Общество с ограниченной ответственностью "Эндокринные технологии" Лекарственная форма для высвобождения дротаверина в полости рта
WO2021228358A1 (en) 2020-05-11 2021-11-18 Symrise Ag A solid mucoadhesive composition
WO2024016113A1 (en) * 2022-07-18 2024-01-25 Yimin Sun Sublingual mucus adhesion drug delivery

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4416927C1 (de) * 1994-05-13 1995-08-31 Lohmann Therapie Syst Lts Vorrichtung zur Abgabe von Wirkstoffen aus Haftschmelzklebern, Verfahren zu ihrer Herstellung und ihre Verwendung
US5639469A (en) * 1994-06-15 1997-06-17 Minnesota Mining And Manufacturing Company Transmucosal delivery system
FR2762513B1 (fr) * 1997-04-23 2003-08-22 Permatec Pharma Ag Comprimes bioadhesifs

Also Published As

Publication number Publication date
US20090110717A1 (en) 2009-04-30
BRPI0711168A2 (pt) 2011-08-23
AU2007245265A1 (en) 2007-11-08
CN101437546A (zh) 2009-05-20
CA2650040A1 (en) 2007-11-08
JP2009535397A (ja) 2009-10-01
KR20090029710A (ko) 2009-03-23
WO2007125545A3 (en) 2008-02-21
WO2007125545A2 (en) 2007-11-08
RU2008147413A (ru) 2010-06-10
EP2015779A2 (en) 2009-01-21

Similar Documents

Publication Publication Date Title
AR060836A1 (es) Un disco trans-mucosa para administrar un agente activo, una composicion trans-mucosa y el metodo de administracion obtenido
AR048705A1 (es) Composiciones farmaceuticas para el tratamiento de los trastornos sexuales ii
AR049985A1 (es) Tratamiento de combinacion para enfermedades malignas no hematologicas
PE20142319A1 (es) Tratamiento de esclerosis multiple con combinacion de laquinimod y acetato de glatiramero
CO6220969A2 (es) Adminsitracion semanal de inhibidores de peptidasa de dipeptidilo
CO6160321A2 (es) Uso de 2-6-(3-amino-piperidin-1-il)-3-metil-2,4-dioxo-3,4-dihidro-2h-pirimidin-1-ilmetil-4-fluoro-benzonitrilo
AR065579A1 (es) Mejoras en composiciones medicinales o relativas a las mismas
AR068185A1 (es) Composiciones de tabletas de desintegracion oral de lamotrigina
CR9261A (es) Composiciones terapeuticas para la administracion intranasal de ketorolac
AR071728A1 (es) Terapia con intervalos para el tratamiento del tinnitus
AR096892A1 (es) Una combinación farmacéutica para el tratamiento del melanoma
CL2011000798A1 (es) Uso de etexilato de dabigatran o una sal del mismo para preparar un medicamento util para la prevencion del ictus en pacientes que padecen fibrilacion auricular.
ATE494889T1 (de) Pharmazeutische kombination mit 3- (3- dimethylamino-1-ethyl-2-methyl-propyl)-phenol und paracetamol
CY1115245T1 (el) Φαρμακευτικη συνθεση που συνδυαζει διαφορους φλεβοτονικους και αγγειοπροστατευτικους παραγοντες για τη θεραπεια χρονιας φλεβικης ανεπαρκειας
CO6592015A2 (es) Métodos y composiciones para reducir o prevenir la cladificación vascular durante el tratamiento de diálisis peritoneal
BR112012030641B8 (pt) Usos e composições para terapia farmacêutica oral
MX2009011900A (es) Curacion de herida diabetica.
AR048318A1 (es) Formulaciones de matriz orales que comprenden licarbazepina
AR080096A1 (es) Tratamiento combinado de cancer de pancreas con gemcitabina y masitinib
AR046036A1 (es) Composiciones de risedronato y metodos para su uso
GT200000071A (es) Nuevas combinaciones farmaceuticas para inhibidores de la nos.
ECSP10010567A (es) Utilizacion de dronedarona para preparar un medicamento para el tratamiento de pacientes con arritmia y que tienen un incremento del nivel de creatinina debido a la administracion de dronedarona
AR065582A1 (es) Mejoras en composiciones medicinales o relativas a las mismas
AR075866A1 (es) Una dosis de ave5026 para el tratamiento de tromboembolismo venoso en pacientes con deterioro renal severo. uso. composicion farmaceutica.
PA8651401A1 (es) Formas de dosificacion oral solidas que contienen una dosis baja de estradiol

Legal Events

Date Code Title Description
FB Suspension of granting procedure